{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:55:28Z","timestamp":1788566128377,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"2024 University-Enterprise Integrated Development \u201cQilu Research Fund\u201d Project","award":["XQQL202408"],"award-info":[{"award-number":["XQQL202408"]}]},{"name":"2024 Key Research Project Fund","award":["WK2024ZZD28"],"award-info":[{"award-number":["WK2024ZZD28"]}]},{"name":"2023 Anhui Provincial Health and Wellness Research Project","award":["AHWJ2023Bba20065"],"award-info":[{"award-number":["AHWJ2023Bba20065"]}]},{"name":"Anhui Province Clinical Medicine Research and Transformation Program","award":["202427b10020034"],"award-info":[{"award-number":["202427b10020034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The mechanism linking body fat percentage (BFR) and non-alcoholic fatty liver disease (NAFLD) remains unclear. This study investigated whether the metabolic score for insulin resistance (METS-IR) mediates this relationship and examined threshold effects and population heterogeneity. In this cross-sectional study of 6281 participants from the 2011\u20132018 National Health and Nutrition Examination Survey (NHANES), logistic regression with restricted cubic splines was used to evaluate the BFR\u2013NAFLD association and identify a threshold. A causal mediation analysis quantified the proportion of the BFR\u2013NAFLD association mediated by METS-IR, and subgroup analyses examined differences by sex, race, and income. BFR was positively associated with NAFLD (OR per 1% increase\u2009=\u20091.12, 95% CI 1.06\u20131.20), with a threshold at 25.103% BFR; below this point, NAFLD risk rose sharply (OR\u2009=\u20091.61) and above it the association plateaued (OR\u2009=\u20091.09). METS-IR mediated 84.7% (95% CI 80.5\u201390%) of the BFR\u2013NAFLD association and exhibited an inflection at 36.066 (OR\u2009=\u20091.72 below vs. 1.47 above this value). The BFR\u2013NAFLD association was stronger in men (OR\u2009=\u20091.32), non-Hispanic Blacks (OR\u2009=\u20091.15), and low-income individuals (OR\u2009=\u20091.13) (P for interaction\u2009&lt;\u20090.05). METS-IR mediates most of the relationship between body fat and NAFLD, with a clear threshold effect observed. Early intervention targeting insulin resistance may curb NAFLD progression, especially in individuals with BFR below 25%. These findings provide epidemiological evidence for the metabolic mechanism of NAFLD and inform precision prevention strategies.<\/jats:p>","DOI":"10.1038\/s41598-025-10765-w","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T15:30:40Z","timestamp":1752161440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nonlinear relationship between body fat percentage and NAFLD mediated by METS-IR: threshold effects and subgroup differences"],"prefix":"10.1038","volume":"15","author":[{"given":"Haiyuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianzhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fubao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"10765_CR1","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1097\/HEP.0000000000000278","volume":"78","author":"SR Sharpton","year":"2023","unstructured":"Sharpton, S. R. & Loomba, R. Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC. Hepatology 78, 1896\u20131906 (2023).","journal-title":"Hepatology"},{"key":"10765_CR2","doi-asserted-by":"crossref","unstructured":"Sandireddy, R. et al. Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases. Front. Cell. Dev. Biol. 12, 1433857 (2024).","DOI":"10.3389\/fcell.2024.1433857"},{"key":"10765_CR3","doi-asserted-by":"publisher","first-page":"e16128","DOI":"10.1111\/liv.16218","volume":"45","author":"A Mantovani","year":"2025","unstructured":"Mantovani, A. et al. MASLD is associated with an increased long-term risk of atrial fibrillation: an updated systematic review and meta-analysis. Liver Int. 45, e16128 (2025).","journal-title":"Liver Int."},{"key":"10765_CR4","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1093\/eurjpc\/zwad297","volume":"30","author":"Z Xiao","year":"2023","unstructured":"Xiao, Z. et al. Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease. Eur. J. Prev. Cardiol. 30, 1924\u20131934 (2023).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10765_CR5","doi-asserted-by":"crossref","unstructured":"Gurevitz, C. & Rosenson, R. Metabolic Dysfunction-Associated steatotic liver disease, hypertriglyceridemia and cardiovascular risk. Eur. J. Prev. Cardiol. published online Dec.\u202f4(2024).","DOI":"10.1093\/eurjpc\/zwae388"},{"key":"10765_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","volume":"15","author":"Y Geng","year":"2021","unstructured":"Geng, Y., Faber, K., De Meijer, V., Blokzijl, H. & Moshage, H. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hep. Intl. 15, 21\u201335 (2021).","journal-title":"Hep. Intl."},{"issue":"1","key":"10765_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","volume":"48","author":"G Musso","year":"2009","unstructured":"Musso, G., Gambino, R. & Cassader, M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog. Lipid Res. 48 (1), 1\u201326 (2009).","journal-title":"Prog. Lipid Res."},{"key":"10765_CR8","doi-asserted-by":"crossref","unstructured":"Dludla, P. et al. N-Acetyl cysteine targets hepatic lipid accumulation to curb oxidative stress and inflammation in NAFLD: a comprehensive analysis of the literature. Antioxidants 9 (12),1283(2020).","DOI":"10.3390\/antiox9121283"},{"key":"10765_CR9","doi-asserted-by":"crossref","unstructured":"Scorletti, E. & Carr, R. A new perspective on NAFLD: focusing on lipid droplets. J. Hepatol. 76(4),934-945(2021).","DOI":"10.1016\/j.jhep.2021.11.009"},{"key":"10765_CR10","doi-asserted-by":"crossref","unstructured":"Ariya, M. et al. Assessment of the association between body composition and risk of non-alcoholic fatty liver. PLoS ONE 16 (4), e0249223(2021).","DOI":"10.1371\/journal.pone.0249223"},{"key":"10765_CR11","doi-asserted-by":"crossref","unstructured":"Kim, H. Y. et al. Relative fat mass at baseline and its early change May be a predictor of incident nonalcoholic fatty liver disease. Sci. Reports 10(1),17491 (2020).","DOI":"10.1038\/s41598-020-74659-9"},{"key":"10765_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.7570\/jomes24005","volume":"33","author":"D Kim","year":"2024","unstructured":"Kim, D., Cholankeril, G. & Ahmed, A. Association between body fat distribution and nonalcoholic fatty liver disease\/fibrosis based on race\/ethnicity. J. Obes. Metabol. Syndr.. 33, 326\u2013336 (2024).","journal-title":"J. Obes. Metabol. Syndr."},{"key":"10765_CR13","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1007\/s00125-016-3966-8","volume":"59","author":"G Clough","year":"2016","unstructured":"Clough, G. et al. Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex evaluation of fatty liver and cardiovascular markers in NAFLD with OMacor therapy trial (WELCOME) trial. Diabetologia 59, 1422\u20131429 (2016).","journal-title":"Diabetologia"},{"key":"10765_CR14","doi-asserted-by":"crossref","unstructured":"Xu, G., Wu, Y., Chen, J., Xiang, D. & Li, D. The relationship between muscle mass and fat content in body composition and non-alcoholic fatty liver disease in the Chinese general population: a cross-sectional study. Front. Med. 11,1384366(2024).","DOI":"10.3389\/fmed.2024.1384366"},{"key":"10765_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hep4.1143","volume":"2","author":"L VanWagner","year":"2018","unstructured":"VanWagner, L., Armstrong, M. & Lean, N. A. F. L. D. A not so benign condition? Hepatol. Commun. 2, 5\u20138 (2018).","journal-title":"Hepatol. Commun."},{"key":"10765_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3350\/cmh.2022.0099","volume":"28","author":"JH Lee","year":"2022","unstructured":"Lee, J. H. et al. The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults. Clin. Mol. Hepatol. 28, 814\u2013826 (2022).","journal-title":"Clin. Mol. Hepatol."},{"key":"10765_CR17","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.2147\/DMSO.S409983","volume":"16","author":"H Li","year":"2023","unstructured":"Li, H. et al. Relationship between six insulin resistance surrogates and nonalcoholic fatty liver disease among older adults: a cross-sectional study. Diabetes Metabolic Syndrome Obes. 16, 1685\u20131696 (2023).","journal-title":"Diabetes Metabolic Syndrome Obes."},{"key":"10765_CR18","doi-asserted-by":"crossref","unstructured":"Cai, X. et al. Dose-response associations of metabolic score for insulin resistance index with nonalcoholic fatty liver disease among a nonobese chinese population: retrospective evidence from a population-based cohort study. Dis. Mark. 2022, 4930355 (2022).","DOI":"10.1155\/2022\/4930355"},{"key":"10765_CR19","doi-asserted-by":"crossref","unstructured":"Fujii, H., Kawada, N. & Jsg-Nafld, J. S. G. O. N. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int. J. Mol. Sci. 21 (11), 3863(2020).","DOI":"10.3390\/ijms21113863"},{"key":"10765_CR20","doi-asserted-by":"crossref","unstructured":"Khan, R., Bril, F., Cusi, K. & Newsome, P. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology .70  (2),711-724(2019).","DOI":"10.1002\/hep.30429"},{"key":"10765_CR21","doi-asserted-by":"crossref","unstructured":"Muzurovi\u0107, E., Mikhailidis, D. & Mantzoros, C. Non-Alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabol. Clin. Exp. 119,154770 (2021).","DOI":"10.1016\/j.metabol.2021.154770"},{"key":"10765_CR22","doi-asserted-by":"publisher","first-page":"e0200465","DOI":"10.1371\/journal.pone.0200465","volume":"13","author":"N Achamrah","year":"2018","unstructured":"Achamrah, N. et al. Comparison of body composition assessment by DXA and BIA according to the body mass index: a retrospective study on 3655 measures. PLoS One. 13, e0200465 (2018).","journal-title":"PLoS One"},{"key":"10765_CR23","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. Diet supplementation of luteolin before fatty liver formation improves hepatic steatosis in obese mice by inhibiting visceral adipose tissue lipolysis. Mol. Nutr. Food Res. 67(7), e2200478(2023).","DOI":"10.1002\/mnfr.202200478"},{"key":"10765_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2217\/dmt.14.30","volume":"4","author":"Y Matsuzawa","year":"2014","unstructured":"Matsuzawa, Y. Obesity and metabolic syndrome: the contribution of visceral fat and adiponectin. Diabetes Manage. 4, 391\u2013401 (2014).","journal-title":"Diabetes Manage."},{"key":"10765_CR25","doi-asserted-by":"crossref","unstructured":"Unamuno, X. et al. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur. J. Clin. Investig. 48 (9), e12997(2018).","DOI":"10.1111\/eci.12997"},{"key":"10765_CR26","doi-asserted-by":"crossref","unstructured":"Gawa\u0142ko, M. et al. Adiposity-associated atrial fibrillation: molecular determinants, mechanisms and clinical significance. Cardiovasc. Res.119(3),614-630 (2022).","DOI":"10.1093\/cvr\/cvac093"},{"key":"10765_CR27","doi-asserted-by":"crossref","unstructured":"Yki-J\u00e4rvinen, H. & Ceramides A cause of insulin resistance in nonalcoholic fatty liver disease in both murine models and humans. Hepatology 71(4),1499-1501 (2020).","DOI":"10.1002\/hep.31095"},{"key":"10765_CR28","doi-asserted-by":"crossref","unstructured":"Kwon, H. & Pessin, J. Adipokines mediate inflammation and insulin resistance. Front. Endocrinol. 4 ,71(2013).","DOI":"10.3389\/fendo.2013.00071"},{"key":"10765_CR29","doi-asserted-by":"crossref","unstructured":"Targher, G., Corey, K. & Byrne, C. NAFLD, and cardiovascular and cardiac diseases: factors influencing risk, prediction and treatment. Diabetes Metabol.47(2),101215 (2021).","DOI":"10.1016\/j.diabet.2020.101215"},{"key":"10765_CR30","doi-asserted-by":"crossref","unstructured":"Byrne, C. & Targher, G. NAFLD as a driver of chronic kidney disease. J. Hepatol. 72(4),785-801(2020).","DOI":"10.1016\/j.jhep.2020.01.013"},{"key":"10765_CR31","unstructured":"Lim, G. E. H. et al. An observational data Meta-Analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 21(3),619-629.e7(2021)."},{"key":"10765_CR32","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher, G., Byrne, C. & Tilg, H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut 69, 1691\u20131705 (2020).","journal-title":"Gut"},{"key":"10765_CR33","unstructured":"Haczeyni, F. Mechanism and significance of adipose inflammatory recruitment. (2015)."},{"key":"10765_CR34","doi-asserted-by":"crossref","unstructured":"Ala, M. & Eftekhar, S. Weight loss breaks the bond between nonalcoholic fatty liver disease and cardiovascular diseases: a clinical and epidemiological perspective. Obes. Rev. 24 (6), e13563(2023).","DOI":"10.1111\/obr.13563"},{"key":"10765_CR35","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12072-021-10143-4","volume":"15","author":"T Ito","year":"2021","unstructured":"Ito, T. et al. The epidemiology of NAFLD and lean NAFLD in japan: a meta-analysis with individual and forecasting analysis, 1995\u20132040. Hep. Intl. 15, 366\u2013379 (2021).","journal-title":"Hep. Intl."},{"key":"10765_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye, Q. et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 5, 739\u2013752 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10765_CR37","doi-asserted-by":"publisher","first-page":"e0249223","DOI":"10.1371\/journal.pone.0249223","volume":"16","author":"M Ariya","year":"2021","unstructured":"Ariya, M. et al. Assessment of the association between body composition and risk of non-alcoholic fatty liver. PLOS ONE. 16, e0249223 (2021).","journal-title":"PLOS ONE"},{"key":"10765_CR38","doi-asserted-by":"crossref","unstructured":"Saleh, A., AbdElaal, Z. & Bekheet, M. Insulin resistance and metabolic syndrome in patients with non-alcoholic fatty liver disease.EKB J. Manag. Syst. 48, 1\u201325 (2017).","DOI":"10.21608\/bnni.2017.4234"},{"key":"10765_CR39","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.2147\/DMSO.S476398","volume":"17","author":"Xuan","year":"2024","unstructured":"Xuan et al. METS-IR, a novel simple insulin resistance index, is associated with NAFLD in patients with type 2 diabetes mellitus. Diabetes Metabol. Syndrome Obes. 17, 3481\u20133490 (2024).","journal-title":"Diabetes Metabolic Syndrome Obes."},{"key":"10765_CR40","first-page":"1","volume":"184","author":"TC Chen","year":"2020","unstructured":"Chen, T. C., Clark, J., Riddles, M., Mohadjer, L. & Fakhouri, T. National health and nutrition examination survey, 2015\u20132018: sample design and Estimation procedures. Vital Health Stat. 2. 184, 1\u201335 (2020).","journal-title":"Vital Health Stat. 2"},{"key":"10765_CR41","doi-asserted-by":"crossref","unstructured":"Lee, J. H. et al. Metabolic score for insulin resistance is inversely related to incident advanced liver fibrosis in patients with non-alcoholic fatty liver disease. Nutrients. 14 (15),3039(2022).","DOI":"10.3390\/nu14153039"},{"key":"10765_CR42","doi-asserted-by":"crossref","unstructured":"Zhang, L. et al. Association of the metabolic score for insulin resistance with cardiovascular diseases, cardiovascular and all-cause mortality in Chinese hypertensive population. Front. Endocrinol. 14 ,1326436(2024).","DOI":"10.3389\/fendo.2023.1326436"},{"key":"10765_CR43","doi-asserted-by":"crossref","unstructured":"Contreras, D., Gonz\u00e1lez-Rocha, A., Clark, P. & Barquera, S. & Denova-Guti\u00e9rrez, E. Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: systematic review and meta-analysis. Ann. Hepatol. 28(1),100873 (2022).","DOI":"10.1016\/j.aohep.2022.100873"},{"key":"10765_CR44","doi-asserted-by":"crossref","unstructured":"Carli, F. et al. Fatty liver index (FLI) identifies not only individuals with liver steatosis but also at high cardiometabolic risk. Int. J. Mol. Sci. 24 (19),14651(2023).","DOI":"10.3390\/ijms241914651"},{"key":"10765_CR45","doi-asserted-by":"crossref","unstructured":"Ch\u00e1vez, L. C. et al. P- 47 Accuracy of mafld-s score to diagnose hepatic steatosis in a group of apparently healthy people. Ann. Hepatol.  29, Supplement\u202f1, 101234(2024).","DOI":"10.1016\/j.aohep.2023.101234"},{"key":"10765_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni, G. et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33\u201333 (2006).","journal-title":"BMC Gastroenterol."},{"key":"10765_CR47","doi-asserted-by":"crossref","unstructured":"Hou, Y. et al. Association of METS-IR index with type 2 diabetes: a cross-sectional analysis of National health and nutrition examination survey data from 2009 to 2018. PLOS ONE .19 (11), e0308597(2024).","DOI":"10.1371\/journal.pone.0308597"},{"key":"10765_CR48","doi-asserted-by":"crossref","unstructured":"Li, N. Analysis of the impact of family education level on household income: a study based on the CHFS database. Int. J. Acc. Finance Stud. 6, 50 (2023).","DOI":"10.22158\/ijafs.v6n1p50"},{"key":"10765_CR49","doi-asserted-by":"crossref","unstructured":"Liu, X. Household Income and Education: An Empirical Research Based on CFPS. Adv. Econ. Manag. Polit. Sci. 37, 25\u201330(2023).","DOI":"10.54254\/2754-1169\/37\/20231828"},{"key":"10765_CR50","doi-asserted-by":"crossref","unstructured":"Chen, Q. Impact of annual household income on the learning motivation of middle school students. SHS Web Conf. 193, 02005(2024).","DOI":"10.1051\/shsconf\/202419302005"},{"key":"10765_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-food-032519-051827","volume":"11","author":"H Hendriks","year":"2020","unstructured":"Hendriks, H. Alcohol and human health: what is the evidence?\u00a0Annu. Rev. Food Sci. Technol. 11, 1\u201321 (2020).","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10765_CR52","doi-asserted-by":"crossref","unstructured":"Miyoshi, K., Kimura, Y., Miyawaki, T. & Dietary Habits Nutrition intake, and alcohol consumption based on types of smoking and smoking status: a cross-sectional study. Nutrients .16 (22),3881(2024).","DOI":"10.3390\/nu16223881"},{"key":"10765_CR53","doi-asserted-by":"crossref","unstructured":"Zibaeenezhad, M. et al. Potential of four definitions of metabolic syndrome to discriminate individuals with different 10-year cardiovascular disease risk scores: a cross-sectional analysis of an Iranian cohort. BMJ Open .12 (2), e058333(2022).","DOI":"10.1136\/bmjopen-2021-058333"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10765-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10765-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10765-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:42:31Z","timestamp":1757220151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10765-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10765"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10765-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study received ethical approval from the National Center for Health Statistics Ethics Review Board under protocols #2011-17 and #2016-04. Written informed consent was obtained from all participants prior to their enrollment in the research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board"}}],"article-number":"24917"}}